During the past decade, New Orleans Center for Clinical Research conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 67 clinical trials were completed, i.e. on average, 84.8% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 46 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Orleans Center for Clinical Research" #1 sponsor was "Pfizer" with 21 trials, followed by "Bristol-Myers Squibb" with 8 trials sponsored, "Genentech, Inc." with 7 trials sponsored, "RAI Services Company" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 96 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Orleans Center for Clinical Research" #1 collaborator was "Celerion" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Covance" with 2 trials as a collaborator and "Bavarian Nordic" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "New Orleans Center for Clinical Research" are "Alzheimer's Disease" (7 trials), "Tobacco Use" (7 trials), "Smoking" (6 trials), "Migraine, With or Without Aura" (5 trials) and "Chronic Obstructive Pulmonary Disease" (4 trials). Many other conditions were trialed in "New Orleans Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "New Orleans Center for Clinical Research" are "Drug" (120 trials), "Other" (18 trials), "Biological" (17 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "Rimegepant" (4 trials), "placebo" (4 trials), "Salmeterol" (3 trials) and "AC2993" (2 trials). Other intervention names were less common.

The vast majority of trials in "New Orleans Center for Clinical Research" are 133 trials for "All" genders, 8 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "New Orleans Center for Clinical Research". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 129 completed trials in New Orleans Center for Clinical Research, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in New Orleans Center for Clinical Research, 44 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 12 trials that are defined as “Not Applicable".